Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


25.03.2024

1 ACS Synth Biol
1 Biochem Genet
2 BMC Cancer
1 BMC Health Serv Res
2 BMC Public Health
1 BMC Womens Health
1 BMJ Case Rep
1 Br J Cancer
1 Cancer
1 Cancer Med
2 Comput Biol Med
1 Crit Rev Eukaryot Gene Expr
1 Cureus
1 Diagn Cytopathol
1 Epigenomics
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Surg Oncol
1 Eur Rev Med Pharmacol Sci
1 Exp Ther Med
1 Front Public Health
2 Gynecol Oncol
1 Gynecol Oncol Rep
1 Hum Vaccin Immunother
1 Int J Epidemiol
1 Int J Gynaecol Obstet
1 Int J Surg
1 J Biomol Struct Dyn
1 J Cancer
1 J Clin Lab Anal
2 J Clin Virol
1 J Eval Clin Pract
3 J Gynecol Oncol
1 J Med Screen
1 J Natl Cancer Inst
1 J Oncol Pharm Pract
1 J Womens Health (Larchmt)
1 JAMA Oncol
2 JCO Glob Oncol
1 Med Biol Eng Comput
1 Methods Mol Biol
1 Neoplasma
2 PLoS One
1 Rep Pract Oncol Radiother
1 Sci Rep
1 Taiwan J Obstet Gynecol
2 Transl Oncol
2 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Synth Biol

  1. GHOUNEIMY A, Ali Z, Aman R, Jiang W, et al
    CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics.
    ACS Synth Biol. 2024;13:837-850.
    PubMed         Abstract available


    Biochem Genet

  2. ZHI Y, Du P, Li Y, Liu H, et al
    SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/beta-Catenin Signaling Pathway.
    Biochem Genet. 2024 Mar 21. doi: 10.1007/s10528-024-10770.
    PubMed         Abstract available


    BMC Cancer

  3. CUI X, Wang H, Chen M, Seery S, et al
    Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
    BMC Cancer. 2024;24:349.
    PubMed         Abstract available

  4. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
    BMC Cancer. 2024;24:351.
    PubMed         Abstract available


    BMC Health Serv Res

  5. ALATTAS M, Gordon S, Sabin LL, El-Jardali F, et al
    Equity and unmet need of non-communicable diseases services in Saudi Arabia using a National Household Survey (2019).
    BMC Health Serv Res. 2024;24:346.
    PubMed         Abstract available


    BMC Public Health

  6. AGIMAS MC, Adugna DG, Derseh NM, Kassaw A, et al
    Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
    BMC Public Health. 2024;24:842.
    PubMed         Abstract available

  7. HAMBISA HD, Asfaha BT, Ambisa B, Gudeta Beyisho A, et al
    Common predictors of cervical cancer related mortality in Ethiopia. A systematic review and meta-analysis.
    BMC Public Health. 2024;24:852.
    PubMed         Abstract available


    BMC Womens Health

  8. ZHANG XF, Wu HY, Liang XW, Chen JL, et al
    Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
    BMC Womens Health. 2024;24:182.
    PubMed         Abstract available


    BMJ Case Rep

  9. BARRISON L, Hoskins E
    Cervical cancer in a transgender man: lessons learnt to improve care.
    BMJ Case Rep. 2024;17:e258903.
    PubMed         Abstract available


    Br J Cancer

  10. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    PubMed         Abstract available


    Cancer

  11. NIERENGARTEN MB
    Promising new treatment approaches for locally advanced cervical cancer.
    Cancer. 2024;130:1192.
    PubMed        


    Cancer Med

  12. KOMATSU H, Matsumoto K, Morita M, Nagasawa T, et al
    A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
    Cancer Med. 2024;13:e6968.
    PubMed         Abstract available


    Comput Biol Med

  13. YANG X, Ding B, Qin J, Guo L, et al
    HVS-Unsup: Unsupervised cervical cell instance segmentation method based on human visual simulation.
    Comput Biol Med. 2024;171:108147.
    PubMed         Abstract available

  14. FANG M, Fu M, Liao B, Lei X, et al
    Deep integrated fusion of local and global features for cervical cell classification.
    Comput Biol Med. 2024;171:108153.
    PubMed         Abstract available


    Crit Rev Eukaryot Gene Expr

  15. XIE N, Mei S, Dai C, Chen W, et al
    HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:45-54.
    PubMed         Abstract available


    Cureus

  16. XU B, Qian M, Zhu L, Lu Z, et al
    Study on the Relationship Between Uncertainty Tolerance and Positive Acceptance in Postoperative Patients With Cervical Cancer.
    Cureus. 2024;16:e54414.
    PubMed         Abstract available


    Diagn Cytopathol

  17. MAHAJAN P, Kaur P
    Improving cervical cancer classification in PAP smear images with enhanced segmentation and deep progressive learning-based techniques.
    Diagn Cytopathol. 2024 Mar 22. doi: 10.1002/dc.25295.
    PubMed         Abstract available


    Epigenomics

  18. SRIHARIKRISHNAA S, John FE, Bairy M, Shetty S, et al
    A comprehensive review on the functional role of miRNA clusters in cervical cancer.
    Epigenomics. 2024;16:493-511.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  19. ASHMORE AA, Abdul S, Phillips A, Bali A, et al
    Regular follow-up with cervical cytology is of questionable value following surgical treatment of microinvasive cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:307-310.
    PubMed         Abstract available


    Eur J Surg Oncol

  20. BRUNO M, Bizzarri N, Scambia G, Ferrandina G, et al
    Reply to: 'Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies'.
    Eur J Surg Oncol. 2024 Mar 12:108238. doi: 10.1016/j.ejso.2024.108238.
    PubMed        


    Eur Rev Med Pharmacol Sci

  21. ALHARBI B, Alessa M, Alsayid H, Alareek L, et al
    Magnetic resonance imaging accuracy in assessing depth of invasion in tongue squamous cell carcinomas and predicting cervical nodal metastasis.
    Eur Rev Med Pharmacol Sci. 2024;28:1783-1790.
    PubMed         Abstract available


    Exp Ther Med

  22. GUO Y, Tao M, Jiang M
    [Retracted] MicroRNA?454?3p inhibits cervical cancer cell invasion and migration by targeting c?Met.
    Exp Ther Med. 2024;27:179.
    PubMed         Abstract available


    Front Public Health

  23. WU S, Jiao J, Yue X, Wang Y, et al
    Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019.
    Front Public Health. 2024;12:1358433.
    PubMed         Abstract available


    Gynecol Oncol

  24. ROSS DH, Gomez K, Harmon G, Mysz ML, et al
    Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.
    Gynecol Oncol. 2024;183:33-38.
    PubMed         Abstract available

  25. GASS P, Thiel FC, Haberle L, Ackermann S, et al
    Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
    Gynecol Oncol. 2024;183:25-32.
    PubMed         Abstract available


    Gynecol Oncol Rep

  26. MWENDA V, Mwangi M, Gathecha G, Kibachio J, et al
    Factors associated with late diagnosis of cervical cancer at two national referral hospitals, Kenya 2017: A case control study.
    Gynecol Oncol Rep. 2024;52:101355.
    PubMed         Abstract available


    Hum Vaccin Immunother

  27. ASGEDOM YS, Kebede TM, Seifu BL, Mare KU, et al
    Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis.
    Hum Vaccin Immunother. 2024;20:2326295.
    PubMed         Abstract available


    Int J Epidemiol

  28. DANTONY E, Uhry Z, Fauvernier M, Coureau G, et al
    Multidimensional penalized splines for survival models: illustration for net survival trend analyses.
    Int J Epidemiol. 2024;53:dyae033.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  29. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed         Abstract available


    Int J Surg

  30. WU S, Yue X, Wang Y
    A commentary on 'Effect of preoperative radiotherapy on stage IB2 and IIA2 cervical cancer: A retrospective cohort study'.
    Int J Surg. 2024 Mar 18. doi: 10.1097/JS9.0000000000001314.
    PubMed        


    J Biomol Struct Dyn

  31. HAKAMI MA, Hazazi A, Alsulami MO, Alsaiari AA, et al
    Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
    J Biomol Struct Dyn. 2024 Mar 22:1-14. doi: 10.1080/07391102.2024.2329796.
    PubMed         Abstract available


    J Cancer

  32. ZHAO W, Wen S, Wang X, Wang J, et al
    Targeted regulation of miR-154-5p/Cullin2 pathway by hsa_circ_TRIM22 in promoting human papillomavirus 16 positive cervical cancer progression.
    J Cancer. 2024;15:2137-2146.
    PubMed         Abstract available


    J Clin Lab Anal

  33. YANG D, Lu X, Zhang X, Zhang X, et al
    RACK1 promotes the occurrence and progression of cervical carcinoma.
    J Clin Lab Anal. 2024;38:e25012.
    PubMed         Abstract available


    J Clin Virol

  34. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
    Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
    J Clin Virol. 2024;171:105657.
    PubMed         Abstract available

  35. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
    Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
    J Clin Virol. 2024;171:105649.
    PubMed         Abstract available


    J Eval Clin Pract

  36. LARSON S, McAnany B, Ladd I, Gogoi R, et al
    What do cervical cancer patients know, how do they learn, and who do they tell? A pilot study.
    J Eval Clin Pract. 2024 Mar 18. doi: 10.1111/jep.13964.
    PubMed         Abstract available


    J Gynecol Oncol

  37. TAKEKUMA M
    Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.
    J Gynecol Oncol. 2024;35:e48.
    PubMed        

  38. SHIM SH, Lee JY, Lee YY, Park JY, et al
    Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    J Gynecol Oncol. 2024;35:e66.
    PubMed         Abstract available

  39. CHOI HC, Leung K, Wu JT
    Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program.
    J Gynecol Oncol. 2024;35:e20.
    PubMed         Abstract available


    J Med Screen

  40. SALINGAROS S, Shieh Y, Finkel ML, Polaneczky M, et al
    Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines.
    J Med Screen. 2024 Mar 20:9691413241238960. doi: 10.1177/09691413241238960.
    PubMed         Abstract available


    J Natl Cancer Inst

  41. ARBYN M, Rousta P, Bruni L, Schollin Ask L, et al
    Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer.
    J Natl Cancer Inst. 2024 Mar 19:djae042. doi: 10.1093.
    PubMed        


    J Oncol Pharm Pract

  42. KEFALE B, Engidaw MT, Tesfa D, Molla M, et al
    Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study.
    J Oncol Pharm Pract. 2024;30:270-277.
    PubMed         Abstract available


    J Womens Health (Larchmt)

  43. HOLT HK, Martinez G, Reyes MF, Saraiya M, et al
    Tubal Sterilization and Cervical Cancer Underscreening in the United States.
    J Womens Health (Larchmt). 2024 Mar 19. doi: 10.1089/jwh.2023.0610.
    PubMed         Abstract available


    JAMA Oncol

  44. JONES KF, Osazuwa-Peters OL, Des Marais A, Merlin JS, et al
    Substance Use Disorders Among US Adult Cancer Survivors.
    JAMA Oncol. 2024;10:384-389.
    PubMed         Abstract available


    JCO Glob Oncol

  45. COURT LE, Aggarwal A, Jhingran A, Naidoo K, et al
    Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care.
    JCO Glob Oncol. 2024;10:e2300376.
    PubMed         Abstract available

  46. HANDE V, Ranjan N, Chopra S, Sinha S, et al
    Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2300478.
    PubMed         Abstract available


    Med Biol Eng Comput

  47. CIVIT-MASOT J, Luna-Perejon F, Munoz-Saavedra L, Dominguez-Morales M, et al
    A lightweight xAI approach to cervical cancer classification.
    Med Biol Eng Comput. 2024 Mar 20. doi: 10.1007/s11517-024-03063.
    PubMed         Abstract available


    Methods Mol Biol

  48. GARCIA-VIELMA C, Cortes-Gutierrez EI, Fernandez JL, Davila-Rodriguez MI, et al
    DBD-FISH Using Specific Chromosomal Region Probes for the Study of Cervical Carcinoma Progression.
    Methods Mol Biol. 2024;2784:271-284.
    PubMed         Abstract available


    Neoplasma

  49. ZHAO D, Sun S, Yang Z, Wang P, et al
    The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Neoplasma. 2024;71:70-76.
    PubMed         Abstract available


    PLoS One

  50. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed         Abstract available

  51. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    PubMed         Abstract available


    Rep Pract Oncol Radiother

  52. VAN ANH DT, Thang VH, Dung TA, Huyen TT, et al
    Outcome and toxicity of chemoradiation using volumetric modulated arc therapy followed by 3D image-guided brachytherapy for cervical cancer: Vietnam National Cancer Hospital experience.
    Rep Pract Oncol Radiother. 2024;28:784-793.
    PubMed         Abstract available


    Sci Rep

  53. ZHANG T, Ji T, Duan Z, Xue Y, et al
    Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
    Sci Rep. 2024;14:6379.
    PubMed         Abstract available


    Taiwan J Obstet Gynecol

  54. SRISUTTAYASATHIEN M, Kantathavorn N, Luasiripanthu T, Petchjorm S, et al
    Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
    Taiwan J Obstet Gynecol. 2024;63:192-198.
    PubMed         Abstract available


    Transl Oncol

  55. JIN T, Yin T, Xu R, Liu H, et al
    Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
    Transl Oncol. 2024;44:101938.
    PubMed         Abstract available

  56. HAN M, Wang N, Han W, Liu X, et al
    Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women.
    Transl Oncol. 2024;44:101902.
    PubMed         Abstract available


    Zhonghua Zhong Liu Za Zhi

  57. LI ZM, Liang ZH, Liu N, Wei KR, et al
    [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Zhonghua Zhong Liu Za Zhi. 2024;46:232-238.
    PubMed         Abstract available

  58. ZHANG YM, Wang GC, Liu YJ, Wang YC, et al
    [Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
    Zhonghua Zhong Liu Za Zhi. 2024;46:263-268.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.